Kewaunee Scientific Signs Deal to Acquire Nycom
KEQU is trading near its 52-week low of $32 (1.0% above the low) on elevated volume (2.7× avg).
Summary
Kewaunee Scientific said it has agreed to acquire Nycom, Inc. for a $55M base price, a bolt-on deal for a company with a market value of roughly $97 million. The price is paid with $30M cash at closing (including $1M escrow), a $20M subordinated seller note, and $5M in Kewaunee stock under a 12-month lock-up. The announcement gives no revenue contribution, so the financial impact can't be fully sized yet. It lands after a weak stretch: fiscal Q1 sales fell 6.7% to $66.32 million and diluted EPS dropped to $0.58 from $1.04, with softer life sciences and India demand cited in the 10-Q filed September 11. For a small-cap trading near its 52-week low of $32.00, an acquisition is a real strategic step, and with a base price now on the table the market has a figure to underwrite.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — The $55M price is paid with $30M cash at closing (including $1M escrow), a $20M subordinated seller note, and $5M in Kewaunee stock under a 12-month lock-up.
At the time of this announcement, KEQU was trading at $32.33 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $96.8M. The 52-week trading range was $32.00 to $44.47. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.